Silvia Maffei

Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?

N. Biglia, A. Cagnacci, R. Nappi, 2017, Climacteric : the journal of the International Menopause Society.

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening

M. Andreassi, S. Maffei, N. Botto, 2006, Clinical chemistry and laboratory medicine.

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening testing / Faktor-V-Leiden, Prothrombin G20210A Substitution und Hormontherapie: Indikationen für molekulare Screening Tests

M. Andreassi, S. Maffei, N. Botto, 2006 .

Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy

M. Andreassi, A. Mazzone, S. Maffei, 2011, Climacteric : the journal of the International Menopause Society.

Hormone replacement therapy and cardioprotection. A new dawn? A statement of the 'Gruppo di studio sulle malattie cardiovascolari nella donna' of the societaitaliana di cardiologia on hormone replacement therapy in postmenopausal women

M. Andreassi, C. Vassalle, C. Vitale, 2008 .